Price T Rowe Associates Inc Voyager Therapeutics, Inc. Call Options Transaction History
Price T Rowe Associates Inc
- $869 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VYGR
# of Institutions
130Shares Held
34.7MCall Options Held
39.7KPut Options Held
34.6K-
Black Rock Inc. New York, NY5.31MShares$30.7 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.2MShares$30.1 Million0.5% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.92MShares$22.6 Million0.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.19MShares$18.4 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.29MShares$13.2 Million0.07% of portfolio
About Voyager Therapeutics, Inc.
- Ticker VYGR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,647,600
- Market Cap $223M
- Description
- Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...